# Evidence Binding Rules (v2)

**Version**: 2.0  
**Purpose**: Define how to cite data sources without overwhelming the user  
**Key Change**: Insight-first approach replaces evidence-first  

---

## Core Principle

> **Every claim must be traceable. No claim should lead with its source.**
>
> Evidence binding ensures analytical integrity. But users care about 
> the INSIGHT, not the audit trail. Make evidence available, not prominent.

---

## CRITICAL: Use Actual Names, Dates, and Specific Details

> **Generic language kills quality. Specificity creates trust and actionability.**

### People Specificity

**ALWAYS use actual names from Salesforce data:**

```
âœ… "Schedule follow-up call with Sarah Johnson (CFO) by Friday"
âŒ "Schedule follow-up call with the CFO soon"

âœ… "Lisa Martinez (Champion) has not engaged in 14 days"
âŒ "Your champion hasn't engaged recently"

âœ… "Robert Taylor (VP Operations) requested technical validation"
âŒ "The decision maker needs more information"

âœ… "Contact James Wilson and Maria Garcia before next week"
âŒ "Reach out to key stakeholders"
```

**FORBIDDEN - Never use these generic terms:**
- âŒ "the CFO" â†’ âœ… "Sarah Johnson (CFO)"
- âŒ "your champion" â†’ âœ… "Lisa Martinez (Champion)"
- âŒ "the decision maker" â†’ âœ… "Robert Taylor (VP Operations)"
- âŒ "key stakeholders" â†’ âœ… "Sarah Johnson and Lisa Martinez"
- âŒ "the buyer" â†’ âœ… "James Wilson (Procurement Director)"
- âŒ "the team" â†’ âœ… "Sarah Johnson, Lisa Martinez, and Robert Taylor"

**How to extract names:**
```
Contact Role: [ContactName] ([ContactRole]) 
Account Team: [TeamMemberName]
Owner: [OwnerName]

Use merge field syntax: {{{ }}} when implementing
```

---

### Date & Timeline Specificity

**ALWAYS use specific dates and bounded timeframes:**

```
âœ… "by Friday, January 24, 2026"
âŒ "soon"

âœ… "within 48 hours (before CFO meeting on Jan 26)"
âŒ "as soon as possible"

âœ… "Task 'Send ROI Analysis' is 7 days overdue (due Jan 15, today is Jan 22)"
âŒ "ROI task is overdue"

âœ… "No activity in 14 days (last contact: Jan 8)"
âŒ "Deal has been quiet recently"

âœ… "Meeting scheduled for Tuesday, Jan 28 at 2pm"
âŒ "Meeting coming up next week"
```

**FORBIDDEN - Never use these vague terms:**
- âŒ "soon" â†’ âœ… "by Friday, January 24"
- âŒ "when possible" â†’ âœ… "within 48 hours"
- âŒ "recently" â†’ âœ… "in the last 14 days"
- âŒ "coming up" â†’ âœ… "scheduled for January 28"
- âŒ "overdue" â†’ âœ… "7 days overdue (due Jan 15)"

---

### Action Specificity

**ALWAYS provide clear, bounded actions with who/what/when:**

```
âœ… "Schedule discovery call with Sarah Johnson (CFO) by Friday to discuss ROI requirements"
âŒ "Follow up with stakeholders about next steps"

âœ… "Prepare technical validation deck and send to Robert Taylor by January 24"
âŒ "Share technical information when ready"

âœ… "Complete MEDDIC scorecard with Lisa Martinez before executive review on Jan 28"
âŒ "Update your MEDDIC assessment"

âœ… "Confirm budget approval process with James Wilson (Procurement) within 48 hours"
âŒ "Check on budget status"
```

**FORBIDDEN - Never use these generic actions:**
- âŒ "follow up with stakeholders" â†’ âœ… "call Sarah Johnson (CFO)"
- âŒ "consider reaching out" â†’ âœ… "Schedule meeting by Friday"
- âŒ "address concerns" â†’ âœ… "Resolve pricing objection in proposal v2"
- âŒ "maintain momentum" â†’ âœ… "Schedule weekly check-ins with Lisa Martinez"
- âŒ "ensure alignment" â†’ âœ… "Get sign-off from Robert Taylor on technical specs"

---

### System & Tool Specificity

**Reference actual systems and documents when available:**

```
âœ… "Competitor comparison vs. Aetna in ROI calculator (Quip doc)"
âŒ "Competitive analysis document"

âœ… "Salesforce Health Cloud implementation timeline"
âŒ "CRM deployment schedule"

âœ… "Q4 benefits enrollment data from Workday"
âŒ "Historical enrollment information"

âœ… "Send proposal v3 (revised pricing on slide 12)"
âŒ "Share updated proposal"
```

---

## The Insight-First Pattern

### Format Hierarchy

Use the highest-appropriate level. Reserve explicit citations for detailed sections.

---

### Level 1: Embedded Data (Use 80% of the Time)

Data point woven naturally into the insight. No explicit citation.

**Pattern:**
```
[Insight with data point naturally embedded]
```

**Examples:**
```
âœ… "This $1.5M deal needs executive sponsor engagement before close."
âœ… "With only 67 days to close and no discovery meeting scheduled..."
âœ… "The 4 engaged stakeholders don't include anyone with budget authority."
âœ… "Stage has been stalled for 45 daysâ€”well beyond your 21-day benchmark."
```

**When to use:**
- Executive summary (Zone 3)
- Key insights in stat cards (Zone 2)
- Action card descriptions (Zone 4)
- Any above-the-fold content

**What makes it work:**
- The number IS the insight ("$1.5M", "67 days", "4 stakeholders")
- No need to say where it came from
- User trusts you got it from Salesforce
- Source available in Zone 6 if they want to verify

---

### Level 2: Parenthetical Source (Use 15% of the Time)

Insight first, with brief source reference in parentheses.

**Pattern:**
```
[Insight statement]. (Source: FieldName)
```

**Examples:**
```
âœ… "No executive sponsor identified. (Source: Contact Roles)"
âœ… "Budget not yet confirmed. (Source: Opportunity custom field)"
âœ… "Deal velocity below average. (Benchmark: 90-day Enterprise cycle)"
```

**When to use:**
- When the data source adds credibility to a surprising claim
- When there might be ambiguity about where info came from
- When referencing a custom field or non-obvious source
- Risk assessment details (Zone 5)

**What makes it work:**
- Insight still leads
- Source is secondary, not prominent
- Parenthetical is naturally de-emphasized
- User can ignore if not interested

---

### Level 3: Inline Citation (Use 5% of the Time)

Explicit "based on" statement after insight, for detailed analysis only.

**Pattern:**
```
[Insight statement]
â†’ Based on: FieldName = Value
```

**Examples:**
```
âœ… "Deal timeline is at significant risk."
   â†’ Based on: Stage Age = 45 days (benchmark: 21 days), Close Date = March 28

âœ… "Champion engagement has dropped off."
   â†’ Based on: Last Contact = 23 days ago, Previous average = 7 days
```

**When to use:**
- Detailed analysis sections (Zone 5) only
- When showing a calculation or comparison
- When the specific value matters for understanding
- When contrasting actual vs. expected

**What makes it work:**
- Appears in "drill-down" sections, not primary view
- User has already opted-in to detail by scrolling
- Shows the work without cluttering the main message

---

### Level 4: Collapsible Data Sources (For Audit Trail)

Full field citations available on demand, collapsed by default.

**Pattern:**
```html
<details>
  <summary>ğŸ“Š Data Sources</summary>
  <ul>
    <li>Deal Size: Opportunity.Amount = $1,500,000</li>
    <li>Close Date: Opportunity.CloseDate = 2026-03-28</li>
    ...
  </ul>
</details>
```

**When to use:**
- End of every generated report (Zone 6)
- Always collapsed by default
- User expands only if they want to verify

**What makes it work:**
- Evidence is available for audit/compliance
- But it's not competing for attention
- Keeps the main output scannable
- Satisfies "show your work" requirement without clutter

---

## What NOT to Do

### âŒ Anti-Pattern 1: Evidence-First

```
WRONG:
"Evidence: Opportunity.Amount = $1,500,000
 Evidence: Opportunity.StageName = Needs Analysis
 Evidence: Opportunity.Probability = 20%
 
 Based on this data, the deal size is significant and may require 
 executive involvement."
```

**Problems:**
- User has to wade through data to find the insight
- Field API names are technical jargon
- "Based on this data" buries the lead
- Feels like reading a database query result

**Fix:**
```
CORRECT:
"This $1.5M deal requires executive sponsor engagementâ€”it's still 
in early qualification with only 20% probability."
```

---

### âŒ Anti-Pattern 2: Over-Citation

```
WRONG:
"The opportunity name is 'McDonald's Q1 Expansion' (Evidence: 
Opportunity.Name). The account is McDonald's Corporation (Evidence: 
Account.Name). The amount is $1,500,000 (Evidence: Opportunity.Amount). 
The close date is March 28, 2026 (Evidence: Opportunity.CloseDate)."
```

**Problems:**
- Unreadable
- Treats user like an auditor, not a decision-maker
- Every sentence interrupted by citation
- Zero synthesis

**Fix:**
```
CORRECT:
"$1.5M McDonald's deal targeting Q1 close. Currently in early stage 
with 67 days remaining."
```

---

### âŒ Anti-Pattern 3: Citation Without Insight

```
WRONG:
"Evidence: Task.Subject = 'Send ROI Analysis'
 Evidence: Task.Status = 'Open'
 Evidence: Task.ActivityDate = '2026-01-15'"
```

**Problems:**
- So what? What does this mean?
- User has to figure out why this matters
- No actionable conclusion

**Fix:**
```
CORRECT:
"ROI Analysis is overdue (was due Jan 15)â€”this is blocking CFO 
budget approval."
```

---

### âŒ Anti-Pattern 4: Generic Claims Without Data

```
WRONG:
"This deal is at risk and needs immediate attention."
```

**Problems:**
- Vague
- No specifics user can act on
- Why is it at risk? What kind of attention?

**Fix:**
```
CORRECT:
"This deal is at risk: 67 days to close but still in early stage, 
with no executive sponsor and an overdue ROI analysis."
```

---

## Transformation Examples

### Opportunity Analysis

| Evidence-First (Avoid) | Insight-First (Use) |
|------------------------|---------------------|
| "Amount = $1.5M. This is a large deal." | "Large deal ($1.5M) requires executive sponsor." |
| "Probability = 20%." | "Low win confidence (20%)â€”qualification gaps remain." |
| "CloseDate = 2026-03-28. There are 67 days remaining." | "Only 67 days to close from early stage." |
| "StageName = Needs Analysis for 45 days." | "Stalled 45 days in qualificationâ€”exceeds 21-day benchmark." |
| "Contact count = 4." | "4 stakeholders engaged but no CFO access." |

### Risk Assessment

| Evidence-First (Avoid) | Insight-First (Use) |
|------------------------|---------------------|
| "Evidence: No Contact with Role = 'Economic Buyer'" | "No economic buyer identifiedâ€”budget approval at risk." |
| "Evidence: Task overdue by 7 days" | "ROI Analysis overdue 7 daysâ€”blocking CFO meeting." |
| "Evidence: LastActivityDate > 14 days" | "No activity in 14 daysâ€”engagement may be stalling." |
| "Evidence: Competitor field is not empty" | "Active competitive threat: [Competitor] also engaged." |

### Timeline Analysis

| Evidence-First (Avoid) | Insight-First (Use) |
|------------------------|---------------------|
| "Stage Age = 45 days. Benchmark = 21 days." | "2x longer than typical at this stageâ€”velocity concern." |
| "Close Date moved 3 times." | "Close date extended 3 timesâ€”credibility at risk." |
| "Created Date = 2025-10-15, Today = 2026-01-22." | "99-day-old opportunity still in early qualification." |

---

## Context-Specific Guidelines

### Above-the-Fold Content (Zones 1-4)

**Rule:** Use Level 1 (embedded) or Level 2 (parenthetical) only.

```
âœ… ALLOWED:
"$1.5M deal at risk: 67 days to close but early stage."
"No executive sponsor identified. (Source: Contact Roles)"

âŒ NOT ALLOWED:
"Evidence: Amount = $1,500,000..."
"Based on: Opportunity.StageName = 'Needs Analysis'..."
```

### Detailed Analysis (Zone 5)

**Rule:** Level 1, 2, or 3 are all appropriate.

```
âœ… ALLOWED:
"Deal velocity has slowed significantly."
â†’ Based on: Stage Age = 45 days (benchmark: 21 days)
```

### Data Sources Section (Zone 6)

**Rule:** Level 4â€”complete field listing, always collapsed.

```
âœ… REQUIRED:
<details>
  <summary>Data Sources</summary>
  Complete field list with values
</details>
```

---

## Implementation for Prompts

### Injection Text for Stage08

Add this to the prompt assembly:

```
=== EVIDENCE BINDING RULES ===

Every analytical claim must be traceable to Salesforce data, but 
INSIGHT LEADS, EVIDENCE SUPPORTS.

CRITICAL - USE ACTUAL NAMES, NOT GENERIC TERMS:
- âœ… "Sarah Johnson (CFO)" not "the CFO"
- âœ… "by Friday, Jan 24" not "soon"
- âœ… "Schedule call with Lisa Martinez" not "follow up with champion"
- âœ… "7 days overdue (due Jan 15)" not "overdue task"

Extract names using merge fields from the Data Context Mapping provided.

FORBIDDEN PHRASES - Never use:
- "the CFO" / "your champion" / "key stakeholders" / "the decision maker"
- "soon" / "when possible" / "recently" / "coming up"
- "follow up with stakeholders" / "consider reaching out" / "ensure alignment"
- "address concerns" / "maintain momentum"

FORMAT REQUIREMENTS:
1. ABOVE THE FOLD: Embed data naturally into insights
   - Good: "This $1.5M deal needs Sarah Johnson (CFO) engagement"
   - Bad: "Evidence: Amount = $1,500,000. This is significant."

2. DETAILED ANALYSIS: Use inline citations sparingly
   - Good: "Stage stalled 45 days (benchmark: 21 days)"
   - Bad: "Evidence: Stage Age = 45. Evidence: Benchmark = 21."

3. END OF REPORT: Include collapsible data sources section
   - List all fields used
   - Collapsed by default
   - For verification, not primary reading

NEVER:
- Start any sentence with "Evidence:"
- List field values without an insight
- Interrupt flow with multiple citations
- Use API field names in visible text (translate to plain language)
- Use generic terms when actual names are available

ALWAYS:
- Lead with the "so what"
- Use actual names from {{{Contact.Name}}}
- Use specific dates and bounded timeframes
- Weave numbers into natural sentences
- Provide specific, actionable recommendations
- Make data sources available but not prominent
```

### Quality Check Prompt for Stage12

Add this dimension:

```
EVIDENCE APPROPRIATENESS (15%):
Does the output properly balance insight and evidence?

Score 1-3: Evidence-first approach, technical jargon, over-citation
Score 4-6: Mixed approach, some buried insights, inconsistent
Score 7-10: Insight-first, natural data embedding, clean citations
```

---

## Quick Reference

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                    EVIDENCE BINDING v2                          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                 â”‚
â”‚  THE RULE                                                       â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€                                                       â”‚
â”‚  Every claim must be traceable.                                â”‚
â”‚  No claim should lead with its source.                         â”‚
â”‚                                                                 â”‚
â”‚  FORMAT LEVELS (by usage frequency)                            â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                            â”‚
â”‚  Level 1 (80%): Embedded data                                  â”‚
â”‚    "This $1.5M deal needs..."                                  â”‚
â”‚                                                                 â”‚
â”‚  Level 2 (15%): Parenthetical source                           â”‚
â”‚    "No sponsor identified. (Source: Contact Roles)"            â”‚
â”‚                                                                 â”‚
â”‚  Level 3 (5%): Inline citation                                 â”‚
â”‚    "Stage stalled" â†’ Based on: Stage Age = 45 days             â”‚
â”‚                                                                 â”‚
â”‚  Level 4 (always): Collapsible data sources                    â”‚
â”‚    [Expand to view all field citations]                        â”‚
â”‚                                                                 â”‚
â”‚  NEVER DO                                                      â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€                                                       â”‚
â”‚  â€¢ "Evidence: FieldName = Value"                               â”‚
â”‚  â€¢ Start with data, end with insight                           â”‚
â”‚  â€¢ Use API names in user-facing text                           â”‚
â”‚  â€¢ Cite without synthesizing                                   â”‚
â”‚                                                                 â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Version History

| Version | Date | Changes |
|---------|------|---------|
| 1.0 | 2026-01-20 | Initial evidence binding rules |
| 2.0 | 2026-01-22 | Revised to insight-first based on visual review feedback |

---

**File Location:** `staticresources/evidence_binding.md`  
**Loaded By:** `ConfigurationLoader.loadStaticResource('evidence_binding')`  
**Injected At:** Stage08 (Prompt Assembly)
